Preventing Pneumococcal Disease

Published Online: Monday, January 30, 2012
Follow Pharmacy_Times:
Populations at risk for developing pneumococcal disease, including seniors, can benefit from the preventive protection of vaccination. Many adults who are older than 65 years did not receive any vaccination against pneumococcal disease as a child. In addition, adults with comorbid conditions are at additional risk for developing pneumococcal infection, and should educate themselves on the benefits of vaccination for preventing potentially life-threatening illness.


Related Articles
A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.
A new study finds that decreased rates of infection with serotypes of pneumococcal disease the PCV7 vaccine protects against outweigh increased rates of infection with serotypes it does not protect against.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
A decade after the 7-valent pneumococcal conjugate vaccine was introduced, it led to approximately 168,000 fewer annual hospitalizations for pneumonia.
Latest Issues
$auto_registration$